For all media enquiries please contact Jennifer Durante, Head of Communications & Fundraising Email media@melanoma.org.au Phone 0412 798 990.
Melanoma science in race against brain cancer – National Press Club
MIA Co-Medical Directors address the National Press Club of Australia detailing world-first breakthroughs in applying melanoma science to Richard Scolyer’s brain cancer.
A life-saving partnership with Toyota Material Handling
Read more about the partnership, which includes vital financial support for MIA research, and also awareness initiatives for the logistics sector.
A life-changing Flinders Ranges Adventure!
Our 11 Flinders Ranges trekkers have returned safely with new friends, a wonderful sense of achievement and many great memories to treasure. See all the pics and support their efforts!
Cutaneous melanoma: a contemporary overview published in The Lancet
A contemporary overview of Cutaneous melanoma, co-authored by MIA, has been published in The Lancet, one of the world's leading medical journals.
Prof Richard Scolyer receives SMR Lifetime Achievement Award
This prestigious award from the 'Society for Melanoma Research' recognises the contribution Richard has made to global melanoma research over the course of his career.
Community fundraisers making a difference Australia-wide
Read more about the inspiring stories behind the amazing efforts and generosity of our Community Fundraisers.
MPA-MIA Melanoma Community Webinar Series 2023
Watch recordings of our 2023 webinar series. The webinars cover Clinical Trials, Mucosal Melanoma, and Fear of Recurrence.
A warm community spirit at the MIA Amie St Clair Winter Wonderland Ball!
Enjoy our pics from the MIA Amie St Clair Winter Wonderland Ball, which capture all the fun!
In loving memory of Gina Savage
Gina Savage was a bright light to all who knew and loved her. We have created this tribute page so everyone can share their messages and memories.
Major advance for neoadjuvant treatment of melanoma
The PBAC recommends expanding current PBS listing for pembrolizumab immunotherapy to allow neoadjuvant (before surgery) treatment of resected stage IIIB-D melanoma.
Prof Richard Scolyer gains strength from widespread support
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
MIA researchers share learnings on global stage at ASCO23
Read more about how the MIA team continues to play a leading role in pushing melanoma research boundaries at ASCO23, the world's leading clinical oncology conference.
Peter Walls says:
Leanne says:
Maco says: